MedVenture Partners

A-Wave is a manufacturing company that develops and markets medical devices, pharmaceuticals, computer software, and hardware.

A-Wave is a manufacturing company that develops and markets medical devices, pharmaceuticals, computer software, and hardware.

SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.

Avisi Technologies Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing innovative solutions for glaucoma treatment. Founded in 2017, the company has created VisiPlate, a next-generation aqueous shunt that utilizes nanotechnology to provide a defense against blindness caused by glaucoma. This advanced technology aims to improve the effectiveness of glaucoma treatments and enhance patient outcomes.

mediVR, Inc. specializes in the development and sale of therapeutic medical devices that utilize virtual reality, three-dimensional tracking, and artificial intelligence to assist in exercise rehabilitation. The company's flagship product, mediVR Kagura, is a self-exercise device designed to assess motor function, posture balance, and cognitive abilities necessary for walking. By employing engaging activities and games, the device aims to enhance rehabilitation for patients, particularly those recovering from strokes. MediVR markets its products through a network of distributors and operates from its headquarters in Tokyo, Japan, with an additional office in Osaka. Founded in 2016, the company is focused on improving healthcare systems through innovative technology.

CorVista Health, Inc. is a Toronto-based company that specializes in artificial intelligence-based medical imaging solutions, specifically for coronary artery and pulmonary hypertension diseases. Founded in 2012, the company has developed a non-invasive cardiac diagnostic platform that allows physicians to assess heart function without the use of radiation, contrast agents, injections, fasting, or exercise. This innovative technology utilizes advanced mathematics, physics, and cloud computing, enabling the use of a portable device that can operate with a WiFi or cellular connection. CorVista Health's solutions can be implemented in various settings, including doctor's offices, satellite clinics, nursing homes, and mobile units, thereby facilitating timely and accessible cardiac evaluations.

Alivas Inc. is a medical company based in Hongo, Tokyo, Japan, that specializes in developing therapeutic medical devices aimed at treating refractory constipation. Founded in 2017, Alivas emerged as a joint venture between Stanford University and the University of Tokyo, leveraging the Japan Biodesign program to foster innovative solutions in medical device creation. The company's primary focus is on addressing intractable chronic constipation, providing patients with effective treatment options to alleviate their condition and improve their quality of life.

Alivas Inc. is a medical company based in Hongo, Tokyo, Japan, that specializes in developing therapeutic medical devices aimed at treating refractory constipation. Founded in 2017, Alivas emerged as a joint venture between Stanford University and the University of Tokyo, leveraging the Japan Biodesign program to foster innovative solutions in medical device creation. The company's primary focus is on addressing intractable chronic constipation, providing patients with effective treatment options to alleviate their condition and improve their quality of life.

SonoMotion Inc. is a medical device company focused on developing non-invasive solutions for kidney stone disease. Founded in 2012 and based in San Mateo, California, the company offers innovative products such as Break Wave, which safely fragments large kidney stones, and Stone Clear, which aids in clearing the resulting stone fragments within 15 minutes in an office setting, without the need for general anesthesia or X-ray radiation. SonoMotion is actively involved in advancing its technology, with a stone repositioning solution currently undergoing clinical trials and a second-generation stone-breaking technology in development. The company's mission is to provide effective and cost-efficient treatments for kidney stone patients.

PaMeLa Co., Ltd. is a medical device company based in Suita, Japan, founded in 2016. The company focuses on developing innovative technology to measure pain experienced by patients during surgical procedures. By utilizing brain wave analysis, algorithms, and machine learning, PaMeLa aims to create an objective method for quantifying pain. This approach is intended to enhance medical care by providing a scientific basis for pain assessment, thereby improving patient outcomes and treatment strategies.

DO THE SAMURAI, Inc. is a cultural tourism platform based in Tokyo, Japan, established in 2016. The company operates Hotokami, a website and mobile application that connects visitors with shrines and temples across Japan. This platform provides users with a comprehensive directory of historical sites, enabling them to easily locate, explore, and share information about their visits. The service is designed to enhance the experience of worshippers and tourists alike by offering free access to valuable information, allowing users to plan their travels effectively and maintain personal records of their visits.

A-Traction Inc., founded in 2015 and based in Kashiwa, Japan, specializes in the development of surgical robots designed to enhance laparoscopic surgery. The company focuses on creating medical devices that act as collaborative partners for surgeons during operations, promoting safer and more effective surgical procedures. A-Traction's innovative concept, known as ANSUR, allows the robotic system to assist surgeons by moving in tandem with their actions, thereby improving the overall surgical experience. The company's mission is to commercialize advanced surgery support robots that leverage their lightweight design to provide high-quality surgical outcomes for a greater number of patients.

BMG is a medical company focused on the development, manufacturing, and sales of biomedical polymer materials and medical devices. The company specializes in research and development services aimed at creating biomaterial products and medical sutures. BMG offers biodegradable and absorbable polymer materials for medical applications, including domestically produced polymers for bioabsorbable sutures. Through its innovative products, BMG aims to provide patients with advanced alternatives, contributing to improved health outcomes globally.

A-Traction Inc., founded in 2015 and based in Kashiwa, Japan, specializes in the development of surgical robots designed to enhance laparoscopic surgery. The company focuses on creating medical devices that act as collaborative partners for surgeons during operations, promoting safer and more effective surgical procedures. A-Traction's innovative concept, known as ANSUR, allows the robotic system to assist surgeons by moving in tandem with their actions, thereby improving the overall surgical experience. The company's mission is to commercialize advanced surgery support robots that leverage their lightweight design to provide high-quality surgical outcomes for a greater number of patients.

Biomedical Solutions, Inc. is a Tokyo-based company established in 2012 by brothers Kazuya and Yasuhiro Shobayashi. The firm specializes in the research and development of medical devices aimed at treating intracranial infarctions, including catheters and stents. By focusing on high-quality products that prioritize safety and efficacy, Biomedical Solutions seeks to meet the needs of its clients in the neurovascular intervention sector. Kazuya brings a background in finance to the company, while Yasuhiro contributes his expertise as a Ph.D. holder in engineering.